NEW YORK (GenomeWeb) – Becton Dickinson said today that the US Food and Drug Administration has given it 510(k) clearance for a molecular test that detects infectious diarrhea caused by harmful intestinal bacteria.

The test is an extension to the firm's BD MAX real-time PCR enteric bacterial panel. With the clearance, the majority of pathogens causing acute gastroenteritis leading to hospitalization can be detected rapidly and accurately on the fully automated BD MAX molecular platform, BD said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.